best glp-1 for prediabetes Medscape | receptor agonists not only support weight loss but also appear to change the way people think about and experience food, according to Developments in Diabetes Medications: The

Sayin, S

This review article will introduce some of the small molecule drugs that are currently receiving significant attention: Orforglipron Orforglipron is an oral small molecule GLP-1RA developed jointly by Eli Lilly and Chia Tai Tianqing Pharmaceutical Group

Clinical studies have used schedules more intensive than those seen in recovery practice: patients with Parkinson's disease received 1,400 mg three times a week for four weeks (Hauser et al., Movement Disorders 2009, PMID 19230029), while studies on skin lightening used 1,200 mg twice a week for six weeks (Alzahrani et al., Cureus 2025, PMID 40013212)

Aggressive treatment may include IV support, vasopressors, corticosteroids, and transient dialysis